Quick Answer
HUTCHMED (China) Ltd reported Stockholders Equity of $1.24 billion for fiscal year 2025.
HUTCHMED (China) Ltd Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.24B | +62.9% |
| 2024 | $759.93M | +4.0% |
| 2023 | $730.54M | +19.7% |
| 2022 | $610.37M | -38.2% |
| 2021 | $986.89M | +103.9% |
| 2020 | $484.12M | +68.1% |
| 2019 | $288.01M | -26.0% |
| 2018 | $389.00M | -15.8% |
| 2017 | $461.73M | +150.6% |
| 2016 | $184.27M | +121.1% |
| 2015 | $83.36M | +46.5% |
| 2014 | $56.91M | -27.1% |
| 2013 | $78.11M | — |
- HUTCHMED (China) Ltd showed an increase of +62.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2013–2025 period, HUTCHMED (China) Ltd’s stockholders equity has grown by 1484.9% (from $78.11 million to $1.24 billion).
- The most recent figure is from HUTCHMED (China) Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: